Latest Articles
Eli Lilly dives into hair loss treatments with investment in AI startup Absci - statnews.com
Eli Lilly dives into hair loss treatments with investment in AI startup Absci statnews.com
Published: June 24, 2026, 8:05 p.m.
Xella Health Launches to Uniquely Detect and Treat 130+ Often-Misdiagnosed Women's Health Conditions - insider.fitt.co
Xella Health Launches to Uniquely Detect and Treat 130+ Often-Misdiagnosed Women's Health Conditions insider.fitt.co
Published: June 24, 2026, 2:13 p.m.
Xella Health Launches to Uniquely Detect and Treat 130+ Often-Misdiagnosed Women's Health Conditions - Fitt Insider
Xella Health Launches to Uniquely Detect and Treat 130+ Often-Misdiagnosed Women's Health Conditions Fitt Insider
Published: June 24, 2026, 2:13 p.m.
The European Parliament demands that women should no longer be diagnosed and treated according to medical standards built for men. - Informat.ro
The European Parliament demands that women should no longer be diagnosed and treated according to medical standards built for men. Informat.ro
Published: June 24, 2026, 7:51 a.m.
New less invasive treatments expand care options for women with endometriosis and fibroids - SearchLight.vc
New less invasive treatments expand care options for women with endometriosis and fibroids SearchLight.vc
Published: June 23, 2026, 11:28 a.m.
UK LGBTQ+ population faces barriers to fertility treatment, research finds - FemTech World
UK LGBTQ+ population faces barriers to fertility treatment, research finds FemTech World
Published: June 22, 2026, 8:37 a.m.
Preetam Jain: Personalized Endometrial Cancer Treatment Based on 4 Key Molecular Subgroups - Oncodaily
Preetam Jain: Personalized Endometrial Cancer Treatment Based on 4 Key Molecular Subgroups Oncodaily
Published: June 22, 2026, 4:56 a.m.
397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D. - Peter Attia MD
397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D. Peter Attia MD
Published: June 22, 2026, 4:35 a.m.
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer - Targeted Oncology
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer Targeted Oncology
Published: June 19, 2026, 5:05 p.m.
Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options - The Union Democrat
Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options The Union Democrat
Published: June 19, 2026, 4:24 p.m.
Link copied to clipboard!